Hence, the difference between severe versus more benign forms of dystrophinopathy is based on the type of genetic alterations [297] and whether particular mutations cause the loss of dystrophin or the production of an abnormal but still semi-functional protein product [255]. Here, DMD is linked to neuromuscular disease caused by qualitative or quantitative defects of dystrophin.